| dc.relation | Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515–23. doi: 10.1111/epi.13121 2. Monti G, Tondelli M, Giovannini G, Bedin R, Nichelli PF, Trenti T, et al. Cerebrospinal fluid tau proteins in status epilepticus. Epilepsy Behav. 2015;49:150-4. doi: 10.1016/j.yebeh.2015.04.030. 3. Vergara JP, Ladino L, Castro CA, Gómez B, Forero E, Vargas, J, Ramírez S. Tratamiento del estado epiléptico, consenso de expertos. Asociación Colombiana de Neurología, Comité de Epilepsia. Acta Neurol Colomb. 2019;35(2):74-88. doi: 10.22379/24224022237 4. Dupont S, Kinugawa K. Nonconvulsive status epilepticus in the elderly. Geriatr Psychol Neuropsychiatr Vieil. 2019;17(S1):25-30. doi: 10.1684/pnv.2019.0782 5. Sutter R, Dittrich T, Semmlack S, Ruegg S, Marsch S, Kaplan PW. Acute systemic complications of convulsive status epilepticus-a systematic review. Crit Care Med. 2018;46(1):138–45. doi: 10.1097/CCM.0000000000002843 6. Hocker S. Systemic complications of status epilepticus–an update. Epilepsy Behav. 2015;49:83–7. doi: 10.1016/j.yebeh.2015.04.024 7. Crawshaw AA, Cock HR. Medical management of status epilepticus: Emergency room to intensive care unit. Seizure. 2020;75:145-152. doi: 10.1016/j.seizure.2019.10.006 8 Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the guideline committee of the American epilepsy society. Epilepsy Curr. 2016;16(1):48–61. doi: 10.5698/1535-7597-16.1.48 9. Kapur J, Elm J, Chamberlain J, Barsan W. et al. Randomized trial of three antivonsulsivant medication for status epilepticus. N Engl J med. 2020;381(22): 2003-2113. doi: 10.1056/NEJMoa1905795 10. Appleton RE, Rainford NE, Gamble C, Messahel S, Humphreys A, Hickey H, Woolfall K, Roper L, Noblet J, Lee E, Potter S, Tate P, Al Najjar N, Iyer A, Evans V, Lyttle MD. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT. Health Technol Assess. 2020;24(58):1-96. doi: 10.3310/hta24580 11. Walker MC. Pathophysiology of status epilepticus. Neuroscience Letter. 2018;667:84–91. doi: 10.1016/j.neulet.2016.12.044 12. Vilella L, González Cuevas M, Quintana Luque M, Toledo M, Sueiras Gil M, Guzmán L, Salas Puig J, Santamarina Pérez E. Prognosis of status epilepticus in elderly patients. Acta Neurol Scand. 2018;137(3):321-328. doi: 10.1111/ane.12867 13. Marchi NA, Novy J, Faouzi M, Stuhli C, Burnand B, Rossetti AO. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. 2015;43(5):1003-9. doi: 10.1097/CCM.0000000000000881 14. Brigo F, Bragazzi N, Nardone R, Trinka E. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus. Epilepsy Behav. 2016;64(Pt A):110–5.13. doi: 10.1016/j.yebeh.2016.09.030 15. Trinka E, Kwan P, Lee B, Dash A. Epilepsy in Asia: Disease burden, management barriers, and challenges. Epilepsia. 2019;60(Suppl 1):7-21. doi: 10.1111/epi.14458 16. Brigo F, Bragazzi NL, Lattanzi S, Nardone R, Trinka E. A critical appraisal of randomized controlled trials on intravenous phenytoin in convulsive status epilepticus. Eur J Neurol. 2018;25(3):451–63. doi: 10.1111/ene.13560 17. Ting Zhao YG, Xuerui Zhua, NaWang , Yanan Chena, Jiahui Zhang , Guinv He, Yan Feng, Jun Xua, Xiong Han, Jiewen Zhang,. Awareness, attitudes toward epilepsy, and first aid knowledge of seizures of hospital staff in Henan, China. Epilepsy Behav. 2017;71:144-8. doi: 10.1016/j.yebeh.2017.06.026 18. Sanchez Fernandez I, Gainza-Lein M, Lamb N, Loddenkemper T. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. Neurology. 2019;92(20): e2339-e2348. doi: 10.1212/WNL.0000000000007503 19. Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, et al. Clasificación operacional de los tipos de crisis por la Liga Internacional contra la Epilepsia: Documento - Posición de la Comisión para Clasificación y Terminología de la ILAE. Epilepsia. 2017;58(4):522–30. doi: 10.1111/epi.13709 20. Ayanda KA, Sulyman D. Determinants of quality of life in adults living with epilepsy. Ann Afr Med. 2020;19(3):164-169. doi: 10.4103/aam.aam_20_18 21. Brigo, F., Del Giovane, C., Nardone, R., Trinka, E., & Lattanzi, S. Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis. Epilepsy Behav. 2019;101(Pt B):106466. doi: 10.1016/j.yebeh.2019.106466 22. Orlandi N, Giovanninin G, Rossi J, Cioclu MC, Meletti S. Clinical outcomes and treatments effectiveness in status epilepticus resolved by antiepileptic drugs: A five‐year observational study. Epilepsia Open. 20205(2);166-175. doi: 10.1002/epi4.12383 23. Yang K, He Y, Xiao B, Wang J, Feng L. Knowledge, attitudes and practice towards epilepsy among medical staff in Southern China: Does the level of hospitals make a difference?. Seizure. 2019;69:221-227. doi: 10.1016/j.seizure.2019.05.002 24. Buddhiraja R, Sharma S, Sharma S, Bansal RK, et al. Epilepsy knowledge, attitudes, and practices among primary healthcare providers in an Indian district. Epilepsy Behav. 2020 Mar;104(Pt A):106899 25. Akça H, Kurt Çitak AN. Characteristics of the knowledge and attitudes of medical students about epilepsy. Epilepsy Behav. 2020;102:106557. doi.org/10.1016/j.yebeh.2019.106557 | |
